Search results
Results from the WOW.Com Content Network
The FDA advised drugmakers to update Covid vaccines to target the KP.2 strain, a descendant of the highly contagious JN.1 variant that spread widely in the U.S. this winter.
(Reuters) -The U.S. Food and Drug Administration said on Thursday it has approved updated COVID-19 vaccines made by Pfizer and Moderna targeting newer variants of the disease in time for a fall ...
The U.S. Food and Drug Administration approved and granted emergency use authorization Thursday for updated COVID-19 vaccines for the upcoming fall and winter season. The FDA said the vaccines ...
The last round of boosters provide some immunity, though, at this point, it has probably waned, and just like the flu vaccine every year, it’s time to update it. So the new vaccines are based on ...
In June, a federal advisory panel said new vaccines against COVID-19 should target the JN.1 lineage, and the FDA recommended manufacturers also target the JN.1 subvariant KP.2.
The US Food and Drug Administration announced Friday that it had advised the makers of the Covid-19 vaccines to formulate their new shots to be a better match for the JN.1 lineage of the coronavirus.
The updated Covid vaccines should be more accessible, experts say. Saturday 16 September 2023 21:00, Maggie O’Neill. The cost of the new Covid vaccines may prohibit some people from getting them ...
The FDA is reversing course on its COVID vaccine guidance: Rather than having a vaccine that targets the older JN.1 variant, the FDA said fall 2024 vaccines should target a newer strain of the virus.